- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06756867
The Effect of Hand Massage with Violet Oil on Pruritus Level and Quality of Life in Patients Receiving Hemodialysis Treatment
December 25, 2024 updated by: KEVSER ÇAĞLA GURLAŞ, TC Erciyes University
The Effect of Hand Massage with Violet Oil on Pruritus Level and Quality of Life in Patients
Itching is among the common problems in individuals receiving hemodialysis (HD) treatment.
Research on the effects of aromatherapy on the symptoms seen in dialysis patients is increasing.
Studies in the literature have found findings that aromatherapy reduces skin dryness and itching.
This study was an experimental study with randomized intervention, placebo and control groups to determine the effect of a 7-minute massage with 2% violet oil on the hand on the non-fistula arm during the dialysis session, 3 times a week for six weeks, on the level of itching and quality of life in individuals receiving HD treatment.
It was planned as.
The project will be determined on individuals who are treated in 7 hemodialysis centers in a provincial center and whose itch severity scores are 3 or higher and who meet the inclusion criteria for the study.According to the results, patients who meet the inclusion criteria will be randomly assigned to intervention, placebo and control groups.
Considering similar studies in the literature, the number of patients to be sampled was determined as 81 people in total, 27 per group, using the G Power program, provided that alpha = 0.05, power = 0.95 and effect size was 0.8165.
Taking into account possible losses, randomization of at least 30 patients will be made to each group.
Ethics committee approval and institutional permissions were obtained for the project.
Verbal and written informed consent forms will be obtained from individuals.
The data of the research will be collected between July 2024 and September 2024.
If the required number of samples cannot be reached, the data collection process will be extended.
In the study, data will be collected using the patient introduction form, 5 D Itch Scale, Kidney Disease Quality of Life Scale (KDQOLTM-36) and patient follow-up charts.
In line with the massage application protocol, in addition to the treatment of patients with high itching scores, hand massage will be applied with violet oil to the individuals in the intervention group and jojoba oil to the placebo group.No action will be taken on the control group.
IBM SPSS 24.0 Statistics and Turcosa programs will be used to evaluate the data.
Power analysis effect size calculations will be made in the Turcosa program.
It is planned to use descriptive (mean, percentage and standard deviation) and analytical statistics (Kolmogorov-Smirnov test, Kruskal-Wallis test, Wilcoxon signed rank test, Mann-Whitney Utest) in data analysis.
In comparisons, a p value of <0.05 will be considered statistically significant.
Study Overview
Status
Enrolling by invitation
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kayseri, Turkey, 38000
- Erciyes University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Those aged 18 and over,
- willing to participate in the study
- Receiving HD treatment in HD units for at least 6 months and 3 sessions per week,
- Continuing dialysis treatment in the same institution,
- Patients who do not develop allergic reactions such as skin irritation, redness, burning and itching after 30 minutes by applying two drops of the oils used in the study to the outer part of the arm.
- There was no change in the treatment program during the study period,
- Having an itch score of 3 or above on the 5-D Itch Scale,
- Individuals who can understand and communicate with Turkish will be included in the research.
Exclusion Criteria:
- Those who have any disease of the respiratory system,
- Those who have any allergies to the essential oils to be used,
- Having a skin lesion in the area to be massaged,
- Patients who use other TIT methods during the treatment process will be excluded from the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: hand massage with violet oil
Hand massage with violet oil during hemodialysis session 3 times a week for 6 weeks
|
In this study, individuals receiving hemodialysis treatment will be massaged with 2% violet oil for 5-7 minutes on the hand on the non-fistula arm during the dialysis session, 3 times a week for six weeks.
|
|
Placebo Comparator: hand massage with placebo jojoba oil
Hand massage with jojoba oil during hemodialysis session 3 times a week for 6 weeks
|
Hand massage with jojoba oil for hemodialysis patients 3 times a week for 6 weeks
|
|
No Intervention: control group
There will be no intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
5D Itch Scale score
Time Frame: 6 weeks
|
Elman et al.
It was developed by in 2010.
The scale evaluates the duration, degree, course, distribution and problems caused by itching experienced in the last two weeks.
The total score of the scale varies between the lowest score of 5 (no itching) and the highest score of 25 points (severe itching).
Duration, degree, direction and disability of itching are scored between 1 and 5 points.
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Kidney Disease Quality of Life Short Form- KDQOLTM-36
Time Frame: 6 weeks
|
It was developed by Hays et al. in 1994 to evaluate the quality of life of individuals receiving dialysis treatment.
The original form of the scale consists of 134 items.
The scale was shortened to 36 items by the Kidney Disease Quality of Life Improvement Center.The KDQOLTM-36 scale, which evaluates the last month of patients, has 36 items consisting of 5 subscales.
SF-12 physical dimension (questions 1,2,3,4,5 and 8), SF-12 mental dimension (questions 6,7,9,10,11 and 12), burden of kidney disease (questions 13-16).
It consists of five subscales: questions), symptom list (questions 17-28), and the impact of kidney disease on daily life (questions 29-36).
The Likert method was used when scoring each item in the scale.
Scores on each dimension range from 0 to 100, with higher scores indicating better health-related quality of life.
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2024
Primary Completion (Estimated)
January 30, 2025
Study Completion (Estimated)
January 31, 2025
Study Registration Dates
First Submitted
December 19, 2024
First Submitted That Met QC Criteria
December 25, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 25, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ErciyessaglıkU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aromatherapy in Hemodialysis Patients with Itching
-
Mansoura UniversityRecruitingNocturnal Polyurea in Patients With BPHEgypt
-
Kissei Pharmaceutical Co., Ltd.CompletedHemodialysis Patients With HyperphosphatemiaJapan
-
Sohag UniversityRecruitingIntradialytic Hypertension in Hemodialysis PatientsEgypt
-
Rutgers, The State University of New JerseyRecruitingCode Status Discussions With Medical In-patientsUnited States
-
Mayo ClinicCompletedRadiofrequency Ablation in Patients With Spinal HardwareUnited States
-
Paracelsus Harz Clinic Bad Suderode.KKS NetzwerkCompletedAdherence to Drug Therapy in Patients With HFrEFGermany
-
Atlantic Health SystemNot yet recruitingPrevalence of OSA in Patients Hospitalized With COPD Exacerbation
-
Assiut UniversityNot yet recruitingPatients with VAP in RICU Patients
-
Changhai HospitalRecruitingChemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal TumorsChina
-
Alaa Mohamed MostafaRecruitingLipid Profile and Ultrasound Findings in Patients With Pancreaticobiliary DiseasesEgypt
Clinical Trials on hand massage with violet oil
-
Afide TufanActive, not recruitingCystoscopy | Aromatherapy | Hand MassageTurkey
-
Chiayi Christian HospitalCompletedGrowth | Preterm Infants | MCT Oil MassageTaiwan
-
Dokuz Eylul UniversityCompletedPain | Hemodynamic Instability | Massage | Endotracheal Aspiration | ReflexologyTurkey
-
Mayo ClinicCompleted
-
TC Erciyes UniversityCompleted
-
Haben Tesfu GebreselassieCompletedNon-malignant Chronic PainTurkey
-
Mersin UniversityCompletedHemodialysis PatientsTurkey
-
Cukurova UniversityEnrolling by invitationPain | Sleep | Self EfficacyTurkey
-
University of YalovaCompleted
-
Giresun UniversityCompleted